Symbols / KLTO $0.52 +0.81% Klotho Neurosciences Inc
KLTO Chart
About
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 56.66M |
| Enterprise Value | 26.60M | Income | -11.29M | Sales | — |
| Book/sh | 0.14 | Cash/sh | 0.10 | Dividend Yield | — |
| Payout | 0.00% | Employees | 3 | IPO | Jun 24, 2024 |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | 3.72 | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | 82.76 |
| Current Ratio | 83.69 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.30 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -71.63% |
| ROE | -198.28% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 108.09M |
| Shs Float | 65.83M | Short Float | 3.27% | Short Ratio | 0.65 |
| Short Interest | — | 52W High | 3.91 | 52W Low | 0.11 |
| Beta | 2.23 | Avg Volume | 2.41M | Volume | 2.18M |
| Target Price | — | Recom | None | Prev Close | $0.52 |
| Price | $0.52 | Change | 0.81% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$-0.98
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
- Klotho Neurosciences pivots to Greenland minerals with new name - Stock Titan Mon, 09 Mar 2026 07
- Klotho Neurosciences Expands Into Mining With Greenland Mines Deal - Yahoo Finance hu, 05 Mar 2026 08
- Klotho Neurosciences Shareholders Approve Reverse Stock Split - tipranks.com ue, 17 Feb 2026 08
- Klotho Neurosciences: What’s Behind The Nine-Fold Rise In KLTO Stock? - Forbes ue, 10 Jun 2025 07
- Klotho Neurosciences Raises $7.75M at $0.2243/Share, Issues Five-Year Warrants - TradingView ue, 24 Feb 2026 08
- Greenland Mines (KLTO) discloses 6.69M shared voting stake, 5.5% - Stock Titan Fri, 13 Mar 2026 07
- Klotho Neurosciences acquires Greenland palladium-gold project - Investing.com Wed, 04 Mar 2026 08
- Biotech Klotho pivots to $68B Greenland metals trove for the West - Stock Titan Wed, 04 Mar 2026 08
- Klotho Neurosciences Completes Greenland Mines Acquisition Merger - tipranks.com ue, 10 Mar 2026 07
- AI-powered Klotho Clock aims to read biological age from a blood test - Stock Titan ue, 24 Feb 2026 08
- Klotho Neurosciences (NASDAQ: KLTO) closes $7,750,000 private placement - Stock Titan Mon, 02 Mar 2026 08
- Klotho Neurosciences (KLTO) clears reverse split and 10M-share equity plan - Stock Titan ue, 17 Feb 2026 08
- Klotho Neurosciences (Nasdaq: KLTO) to rebrand after Greenland Mines deal - Stock Titan Wed, 04 Mar 2026 08
- Klotho Neurosciences (NASDAQ: KLTO) buys Greenland Mines with new Series C preferred - Stock Titan ue, 10 Mar 2026 07
- Klotho Neurosciences (KLTO) sets 34.6M-share stock and warrant sale - Stock Titan Mon, 23 Feb 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
5.54
+777.56%
|
0.63
+9.91%
|
0.57
-48.21%
|
1.11
|
| Selling General And Administration |
|
5.54
+777.56%
|
0.63
+9.91%
|
0.57
-48.21%
|
1.11
|
| General And Administrative Expense |
|
5.54
+777.56%
|
0.63
+9.91%
|
0.57
-48.21%
|
1.11
|
| Salaries And Wages |
|
2.65
|
0.00
-100.00%
|
0.00
-99.83%
|
0.82
|
| Other Gand A |
|
2.89
+357.87%
|
0.63
+10.18%
|
0.57
+99.01%
|
0.29
|
| Total Expenses |
|
5.54
+777.56%
|
0.63
+9.91%
|
0.57
-48.21%
|
1.11
|
| Operating Income |
|
-5.54
-777.56%
|
-0.63
-9.91%
|
-0.57
+48.21%
|
-1.11
|
| Total Operating Income As Reported |
|
-5.54
-777.56%
|
-0.63
-9.91%
|
-0.57
+48.21%
|
-1.11
|
| EBITDA |
|
-5.79
-817.83%
|
-0.63
-9.93%
|
-0.57
+48.22%
|
-1.11
|
| Normalized EBITDA |
|
-5.79
-817.52%
|
-0.63
-9.93%
|
-0.57
+48.22%
|
-1.11
|
| EBIT |
|
-5.79
-817.83%
|
-0.63
-9.93%
|
-0.57
+48.22%
|
-1.11
|
| Total Unusual Items |
|
-0.00
|
—
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.00
|
—
|
—
|
—
|
| Net Income |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Pretax Income |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Net Non Operating Interest Income Expense |
|
-0.36
-367.90%
|
-0.08
-212.79%
|
-0.02
|
0.00
|
| Interest Expense Non Operating |
|
0.36
+367.90%
|
0.08
+212.79%
|
0.02
|
0.00
|
| Net Interest Income |
|
-0.36
-367.90%
|
-0.08
-212.79%
|
-0.02
|
0.00
|
| Interest Expense |
|
0.36
+367.90%
|
0.08
+212.79%
|
0.02
|
0.00
|
| Other Income Expense |
|
-0.25
-325142.31%
|
0.00
-46.94%
|
0.00
+234.09%
|
0.00
|
| Other Non Operating Income Expenses |
|
-0.25
-322628.21%
|
0.00
-46.94%
|
0.00
+234.09%
|
0.00
|
| Gain On Sale Of Security |
|
-0.00
|
—
|
—
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Net Income From Continuing Operation Net Minority Interest |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Net Income From Continuing And Discontinued Operation |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Net Income Continuous Operations |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Normalized Income |
|
-6.15
-769.08%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Net Income Common Stockholders |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Diluted EPS |
|
-0.32
-47167.36%
|
-0.00
-18.15%
|
-0.00
+45.99%
|
-0.00
|
| Basic EPS |
|
-0.32
-47167.36%
|
-0.00
-18.15%
|
-0.00
+45.99%
|
-0.00
|
| Basic Average Shares |
|
19.25
-98.16%
|
1,044.86
+0.00%
|
1,044.86
+0.00%
|
1,044.86
|
| Diluted Average Shares |
|
19.25
-98.16%
|
1,044.86
+0.00%
|
1,044.86
+0.00%
|
1,044.86
|
| Diluted NI Availto Com Stockholders |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
2.46
+12.07%
|
2.19
-13.65%
|
2.54
+143.83%
|
1.04
|
| Current Assets |
|
0.16
+2273.81%
|
0.01
-97.98%
|
0.33
+8.22%
|
0.30
|
| Cash Cash Equivalents And Short Term Investments |
|
0.06
+2169.98%
|
0.00
-96.30%
|
0.08
-74.78%
|
0.30
|
| Cash And Cash Equivalents |
|
0.06
+2169.98%
|
0.00
-96.30%
|
0.08
-74.78%
|
0.30
|
| Cash Financial |
|
0.06
+2169.98%
|
0.00
-96.30%
|
0.08
-74.78%
|
0.30
|
| Receivables |
|
—
|
—
|
0.25
|
0.00
|
| Prepaid Assets |
|
0.09
+2349.74%
|
0.00
+4.72%
|
0.00
+0.00%
|
0.00
|
| Total Non Current Assets |
|
2.30
+5.19%
|
2.19
-1.08%
|
2.21
+199.86%
|
0.74
|
| Goodwill And Other Intangible Assets |
|
2.30
+5.19%
|
2.19
-1.08%
|
2.21
+199.86%
|
0.74
|
| Other Intangible Assets |
|
2.30
+5.19%
|
2.19
-1.08%
|
2.21
+199.86%
|
0.74
|
| Total Liabilities Net Minority Interest |
|
1.27
-21.53%
|
1.62
+19.17%
|
1.36
+8887.60%
|
0.02
|
| Current Liabilities |
|
1.25
-23.04%
|
1.62
+19.17%
|
1.36
+8887.60%
|
0.02
|
| Payables And Accrued Expenses |
|
0.98
+534.78%
|
0.15
+1105.07%
|
0.01
-15.72%
|
0.02
|
| Payables |
|
0.06
-57.90%
|
0.15
+1787.43%
|
0.01
-47.05%
|
0.02
|
| Accounts Payable |
|
0.06
-57.90%
|
0.15
+1787.43%
|
0.01
-47.05%
|
0.02
|
| Current Accrued Expenses |
|
0.91
+36977.03%
|
0.00
-48.12%
|
0.00
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.27
-81.48%
|
1.47
+8.89%
|
1.35
|
—
|
| Current Debt |
|
0.27
-81.48%
|
1.47
+8.89%
|
1.35
|
—
|
| Other Current Borrowings |
|
—
|
0.14
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.02
|
0.00
|
0.00
|
0.00
|
| Stockholders Equity |
|
1.19
+107.33%
|
0.57
-51.52%
|
1.18
+14.89%
|
1.03
|
| Common Stock Equity |
|
1.19
+107.33%
|
0.57
-51.49%
|
1.18
+14.90%
|
1.03
|
| Capital Stock |
|
0.00
+78.98%
|
0.00
-99.82%
|
0.86
+715.68%
|
0.10
|
| Common Stock |
|
0.00
+78.98%
|
0.00
-99.82%
|
0.86
+719.14%
|
0.10
|
| Preferred Stock |
|
0.00
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
27.08
+78.98%
|
15.13
+0.00%
|
15.13
+0.00%
|
15.13
|
| Ordinary Shares Number |
|
27.08
+78.98%
|
15.13
+0.00%
|
15.13
+0.00%
|
15.13
|
| Additional Paid In Capital |
|
11.75
+161.37%
|
4.49
+26.98%
|
3.54
+0.00%
|
3.54
|
| Retained Earnings |
|
-10.56
-169.21%
|
-3.92
-22.00%
|
-3.22
-22.87%
|
-2.62
|
| Total Equity Gross Minority Interest |
|
1.19
+107.33%
|
0.57
-51.52%
|
1.18
+14.89%
|
1.03
|
| Total Capitalization |
|
1.19
+107.33%
|
0.57
-51.52%
|
1.18
+14.89%
|
1.03
|
| Working Capital |
|
-1.09
+32.50%
|
-1.61
-56.62%
|
-1.03
-456.18%
|
0.29
|
| Invested Capital |
|
1.46
-28.54%
|
2.04
-19.29%
|
2.53
+146.25%
|
1.03
|
| Total Debt |
|
0.27
-81.48%
|
1.47
+8.89%
|
1.35
|
—
|
| Net Debt |
|
0.21
-85.80%
|
1.46
+15.16%
|
1.27
|
—
|
| Net Tangible Assets |
|
-1.11
+30.98%
|
-1.61
-56.62%
|
-1.03
-456.18%
|
0.29
|
| Tangible Book Value |
|
-1.11
+30.98%
|
-1.61
-56.54%
|
-1.03
-456.98%
|
0.29
|
| Current Notes Payable |
|
0.27
-79.60%
|
1.33
-1.13%
|
1.35
|
0.00
|
| Derivative Product Liabilities |
|
0.02
|
0.00
|
—
|
—
|
| Duefrom Related Parties Current |
|
—
|
—
|
0.25
|
0.00
|
| Preferred Stock Equity |
|
—
|
—
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.95
-559.30%
|
-0.45
+25.46%
|
-0.60
-111.10%
|
-0.28
|
| Cash Flow From Continuing Operating Activities |
|
-2.95
-559.30%
|
-0.45
+25.46%
|
-0.60
-111.10%
|
-0.28
|
| Net Income From Continuing Operations |
|
-6.15
-769.36%
|
-0.71
-18.19%
|
-0.60
+46.03%
|
-1.11
|
| Other Non Cash Items |
|
0.39
|
—
|
—
|
—
|
| Stock Based Compensation |
|
2.65
|
0.00
-100.00%
|
0.00
-99.83%
|
0.82
|
| Asset Impairment Charge |
|
0.01
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
0.00
|
—
|
—
|
—
|
| Gain Loss On Investment Securities |
|
0.00
|
—
|
—
|
—
|
| Change In Working Capital |
|
0.15
-42.21%
|
0.26
+11047.14%
|
-0.00
-161.75%
|
0.00
|
| Change In Prepaid Assets |
|
-0.09
-52056.07%
|
-0.00
|
0.00
-100.00%
|
0.00
|
| Change In Payables And Accrued Expense |
|
0.18
-30.66%
|
0.26
+11054.41%
|
-0.00
-206.30%
|
0.00
|
| Change In Accrued Expense |
|
1.06
+46746.14%
|
-0.00
-148.12%
|
0.00
|
0.00
|
| Change In Payable |
|
-0.88
-436.01%
|
0.26
+3792.74%
|
-0.01
-418.09%
|
0.00
|
| Change In Account Payable |
|
-0.19
-280.36%
|
0.10
+1560.22%
|
-0.01
+44.77%
|
-0.01
|
| Change In Other Current Liabilities |
|
0.06
|
0.00
|
—
|
—
|
| Investing Cash Flow |
|
-0.12
-617.76%
|
0.02
+119.02%
|
-0.13
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
-0.12
-617.76%
|
0.02
+119.02%
|
-0.13
|
0.00
|
| Capital Expenditure |
|
-0.12
-789.24%
|
-0.01
+88.93%
|
-0.13
|
—
|
| Net Intangibles Purchase And Sale |
|
-0.12
-617.76%
|
0.02
+119.02%
|
-0.13
|
0.00
|
| Purchase Of Intangibles |
|
-0.12
-789.24%
|
-0.01
+88.93%
|
-0.13
|
0.00
|
| Financing Cash Flow |
|
3.13
+794.55%
|
0.35
-30.00%
|
0.50
+100.00%
|
0.25
|
| Cash Flow From Continuing Financing Activities |
|
3.13
+794.55%
|
0.35
-30.00%
|
0.50
+100.00%
|
0.25
|
| Net Issuance Payments Of Debt |
|
2.18
|
0.00
|
—
|
—
|
| Issuance Of Debt |
|
2.18
|
0.00
|
—
|
—
|
| Short Term Debt Issuance |
|
2.18
|
0.00
|
—
|
—
|
| Net Short Term Debt Issuance |
|
2.18
|
0.00
|
—
|
—
|
| Net Common Stock Issuance |
|
0.17
|
0.00
-100.00%
|
0.75
+200.00%
|
0.25
|
| Common Stock Payments |
|
-0.12
|
0.00
|
—
|
—
|
| Repurchase Of Capital Stock |
|
-0.12
|
0.00
|
—
|
—
|
| Net Other Financing Charges |
|
0.78
+122.55%
|
0.35
-30.00%
|
0.50
+100.00%
|
0.25
|
| Changes In Cash |
|
0.06
+183.40%
|
-0.07
+67.52%
|
-0.22
-561.30%
|
-0.03
|
| Beginning Cash Position |
|
0.00
-96.30%
|
0.08
-74.78%
|
0.30
-10.16%
|
0.33
|
| End Cash Position |
|
0.06
+2169.98%
|
0.00
-96.30%
|
0.08
-74.78%
|
0.30
|
| Free Cash Flow |
|
-3.07
-566.23%
|
-0.46
+36.44%
|
-0.72
-155.26%
|
-0.28
|
| Interest Paid Supplemental Data |
|
0.00
-96.87%
|
0.08
+300.00%
|
0.02
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.55
|
0.00
|
0.00
|
0.00
|
| Change In Income Tax Payable |
|
-0.57
|
0.00
|
—
|
—
|
| Change In Tax Payable |
|
-0.57
|
0.00
|
—
|
—
|
| Common Stock Issuance |
|
0.29
|
0.00
-100.00%
|
0.75
+200.00%
|
0.25
|
| Issuance Of Capital Stock |
|
0.29
|
0.00
-100.00%
|
0.75
+200.00%
|
0.25
|
| Sale Of Intangibles |
|
0.00
-100.00%
|
0.04
|
—
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|